Severe ME Day of Understanding and Remembrance: Aug. 8, 2017
Determined to paper the Internet with articles about ME, Jody Smith brings some additional focus to Severe Myalgic Encephalomyelitis Day of Understanding and Remembrance on Aug. 8, 2017 ...
Discuss the article on the Forums.

Immunotherapy against EBV: Targeting EBV infected cells using immunotherapy

Discussion in 'Other Health News and Research' started by Ecoclimber, Feb 5, 2014.

  1. Sushi

    Sushi Senior Member Albuquerque

    Messages:
    14,408
    Likes:
    21,619
    Albuquerque
    Dr. Lerner in Michigan is also giving Cidofovir.

    Sushi
     
    NK17 likes this.
  2. Christopher

    Christopher Senior Member

    Messages:
    573
    Likes:
    261
    Pennsylvania
    Confirmation from someone affiliated with CFI of receipt of the study.
     
  3. Cheesus

    Cheesus Senior Member

    Messages:
    1,244
    Likes:
    5,577
    UK
    http://www.medicalnewstoday.com/articles/272326.php
     
    NK17, Ren, Tito and 6 others like this.
  4. Christopher

    Christopher Senior Member

    Messages:
    573
    Likes:
    261
    Pennsylvania
    Now for funding =)
     
  5. Cheesus

    Cheesus Senior Member

    Messages:
    1,244
    Likes:
    5,577
    UK
    I would guess MS has better funding sources than ME, so it hopefully won't be such a marathon. Fingers crossed it could have positive repercussions in ME.
     
    Ren likes this.
  6. Firestormm

    Firestormm

    Messages:
    5,022
    Likes:
    4,826
    Cornwall England
    It does seem very early days. And to be reporting on this in such a way when the study only comprised one patient seems strange. Then again, if the exposure helps bring interest to the team who worked on it - and funding - then large studies with controls if viable in some way - could produce more significant results that night lead to a better understanding of MS and other conditions perhaps.
     
    Valentijn, aimossy, August59 and 2 others like this.
  7. Esther12

    Esther12 Senior Member

    Messages:
    8,449
    Likes:
    28,523
    Yeah - reporting of these sorts of this always seems a bit scary to me, but they're open about the fact that it's just one person.
     
    aimossy and Firestormm like this.
  8. Christopher

    Christopher Senior Member

    Messages:
    573
    Likes:
    261
    Pennsylvania
    "Don't have anywhere near as much fatigue. Nowhere near as much pain."

    Mr. Pender says in the radio interview that the patient's symptoms improved 2 weeks after the injection, and he has remained improved for 1 YEAR after the injection.

    I spoke with Mr. Pender, and the organization MS Queensland is attempting to get a bigger trial going based on his study. The YouTube video below interviews Professor Pender and the patient from the study. According to the video, they need to raise $400,000 for a trial.

    Story from MS Queensland




     
    Last edited: Feb 7, 2014
    NK17, Iquitos, natasa778 and 3 others like this.
  9. perovyscus

    perovyscus

    Messages:
    96
    Likes:
    57
    Partial results from this trial (with vested interest) were disclosed on April 20, 2017, with 3 of 6 patients improving. It is an exceptionally weak trial design given it is Phase I.

    Lot of normal responses of marginal improvement you would see from a state-of-the-art MS drug but here is one that caught my eye:
    • Reduction in fatigue from 60 at baseline to 9 on the fatigue severity scale (FSS) following last study visit (the FSS provides scores in the range from 9-63)
    Full Results in Feb 2018, additional interim in October 2017.
     
    Last edited: Aug 26, 2017
    anni66 and Esther12 like this.

See more popular forum discussions.

Share This Page